0001042074-17-000007.txt : 20170630
0001042074-17-000007.hdr.sgml : 20170630
20170630130401
ACCESSION NUMBER: 0001042074-17-000007
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170626
FILED AS OF DATE: 20170630
DATE AS OF CHANGE: 20170630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dickinson Klara
CENTRAL INDEX KEY: 0001339895
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17941275
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BOULEVARD, SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2017-06-26
1
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001339895
Dickinson Klara
7999 GATEWAY BOULEVARD, SUITE 130
NEWARK
CA
94560
0
1
0
0
SVP, Regulatory Affairs & QA
/s/ Klara A. Dickinson-Eason
2017-06-29
EX-24
2
klara.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby constitutes and
appoints each of SUJAL SHAH, CHARLES MCWHERTER, DANIEL MENOLD, MATTHEW
HEMINGTON and BRETT WHITE, signing individually, the undersigned's true and
lawful attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director or beneficial owner of more than 10% of a
registered class of securities of CymaBay Therapeutics, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a)of the Securities Exchange
Act of 1934, as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to execute such Forms 3, 4 or 5, complete
and execute any amendment or amendments thereto, and timely file such forms
or amendmentw with the United States Securities and Exchange Commission and
any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by the Company or Cooley LLP.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 29th day of June, 2017.
/s/ Klara A. Dickinson-Eason
Klara A. Dickinson-Eason